Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

First-quarter profits down at Nycomed contrast media:

This article was originally published in Clinica

Executive Summary

Norwegian contrast media and pharmaceuticals manufacturer Hafslund Nycomed has reported lower operating profits for its contrast media division. In the first quarter, profits declined 9% to NKr 553 million ($84 million). First-quarter turnover was down 4% to NKr 1,227 million. The company blames the decline on increased price pressure in the contrast agent market in the US. In March, Nycomed lost its position as preferred supplier to American Health Services (AMHS) (see Clinica No 700/1, p 20). Hafslund Nycomed's group sales in the first quarter were NKr 2,380 million and pre-tax income was NKr 456 million.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT088022

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel